Loading...
Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement
BACKGROUND: Base excision repair (BER) pathway is a DNA repair pathway that is important in carcinogenesis and in response to DNA-damaging chemotherapy. XRCC1 is one of important molecular markers for BER. So far, the role of XRCC1 polymorphisms with clinical outcomes of advanced NSCLC treated with...
Na minha lista:
| Udgivet i: | BMC Cancer |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5526237/ https://ncbi.nlm.nih.gov/pubmed/28743242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3487-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|